Molecular subgroups of medulloblastoma: the current consensus

Keywords

Medulloblastoma, Malignancy, Demographics, Consensus conference, Oncology

References

• OTX1 and OTX2 Expression Correlates With the Clinicopathologic Classification of MedulloblastomasMonika Dudra-Jastrzębska — 2006
• Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.Chunhui Di, Shaoxi Liao, David Cory Adamson — 2005
• Sporadic medulloblastomas contain oncogenic beta-catenin mutations.Russell H. Zurawel, SHARON A. CHIAPPA, Cory Allen — 1998
• Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in MedulloblastomaRobert L. Yauch, Gerrit J.P. Dijkgraaf, Bruno Alicke — 2009
• Central and Extrapontine Myelinolysis: Then…and NowBette K. Kleinschmidt‐DeMasters, Amyn M. Rojiani, Christopher M. Filley — 2006
• Nodule Formation and Desmoplasia in Medulloblastomas—Defining the Nodular/Desmoplastic Variant and Its Biological BehaviorCharles S. McManamy, Jane Pears, Claire Weston — 2007
• Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson — 2010
• Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastomaIngrid Slade, Anne R. Murray, Sandra Hanks — 2011
• Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristicsSarah Fattet, Christine Haberler, Patricia Legoix — 2009
• Mutations in SUFU predispose to medulloblastomaMichael D. Taylor, Ling Liu, Corey Raffel — 2002
• Medulloblastoma in the second decade of life: A specific group with respect to toxicity and managementUri Tabori, Lillian Sung, Juliette Hukin — 2005
• An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)Hazel Rogers, S. Miller, James Lowe — 2009
• Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiationKimberly Stegmaier, Kenneth N. Ross, Sierra A. Colavito — 2004
• Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaPaul A. Northcott, Yukiko Nakahara, Xiaochong Wu — 2009
• Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastomaH. Al-Halabi, André Nantel, Álmos Klekner — 2011
• Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma.Uri Tabori, Lillian Sung, Juliette Hukin — 2006
• Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsDavid W. Ellison, James Dalton, Mehmet Koçak — 2011
• Rapid diagnosis of medulloblastoma molecular subgroupsEd C. Schwalbe, Janet C. Lindsey, Debbie Straughton — 2011
• The genetic landscape of the childhood cancer medulloblastomaD. Williams Parsons, Meng Li, Xiaosong Zhang — 2010
• Wnt/Wingless Pathway Activation and Chromosome 6 Loss Characterise a Distinct Molecular Sub-Group of Medulloblastomas Associated with a Favourable PrognosisSteven C. Clifford, Meryl E. Lusher, Janet C. Lindsey — 2006

Cited by

• Differential Expression of Somatostatin Receptors, P44/42 MAPK, and mTOR Activation in Medulloblastomas and Primitive Neuroectodermal TumorsMonika Ampferl — 2013
• The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma茂樹 伊藤 — 2015
• Sox2: regulation of expression and contribution to brain tumors.R. W. Claus — 2016
• Complete and sustained response of adult medulloblastoma to first-line sonic hedgehog inhibition with vismodegibKari Luojus, Jouni Pulliainen, Helmut Rott — 2016
• Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgeryHuei Huang Kuan, Gee‐Woo Bock, Jumin Lee — 2016
• Medulloblastoma: Molecular Classification-Based Personal TherapeuticsJohanna E. Katchen — 2017
• A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal RhabdomyosarcomaJason B Rogers — 2017
• Oxamate, but Not Selective Targeting of LDH-A, Inhibits Medulloblastoma Cell Glycolysis, Growth and Motility一郎 青木, 直司 松本, 耕史 櫻木 — 2018
• Drug repurposing towards targeting cancer stem cells in pediatric brain tumors李莉蓓, 寇琦, 戚旭 — 2020
• Medulloblastoma: molecular classifications and prognostic associations.Dennis C. Shrieve, Howard Colman — 2012
• Molecular Regulators of Stem Cell Fate and Tumor Development in the CerebellumSonja N. Brun — 2014
• Investigating the role of Dachshund Homolog 1 (DACH1) and miR-200b in Group 4 medulloblastoma pathogenesisCourtney George — 2014
• Understanding the role of the Sonic Hedgehog signaling pathway in cerebellar development and medulloblastoma genesisJoyoti Dey — 2012
• Using genomics for drug discovery in medulloblastomaC. Faria — 2014
• Personalized diagnosis of medulloblastoma subtypes across patients and model systems.Deena M.A. Gendoo, Petr Smirnov, Mathieu Lupien — 2015
• An integrative view on sex differences in brain tumorsTao Sun, Anya Plutynski, Stacey Ward — 2015
• Regional Differences in Glioma: The Role of Pax3 in the Mechanisms and Cellular Origins of Brainstem GliomaKatherine L. Misuraca — 2014
• Somatic CRISPR/Cas9-mediated tumor suppressor disruption enables versatile brain tumor modelingMarc Zuckermann, Volker Hovestadt, Christiane B. Knobbe‐Thomsen — 2015
• Localization of SHH medulloblastoma in mice depends on the age at its initiationJasmin Ohli, Julia E. Neumann, Daniel Grammel — 2015
• Developmentally Regulated Antigens for Immunologic Targeting of Molecular SubtypesChristina Diem, Chi L. L. Pham — 2015

Related papers

• PRMT1 is an important factor for medulloblastoma cell proliferation and survivalGu Xiao, Miao He, Timofey Lebedev — 2022
• Desmoplastic medulloblastoma in an adult patientMehmet Edip Akyol, Abdurrahman Aycan, Celaleddin Soyalp — 2018
• THE MEDICAL IMAGING & PATHOLOGICAL ANALYSIS OF MEDULLOBLASTOMA IN CHILDRENXin Zhong — 2006
• Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastomaSusan Spiller, Ali C. Ravanpay, Andrew W. Hahn — 2006
• Medulloblastoma: From Origin to TreatmentYi Lu — 2020
• Morphophenotype of medulloblastoma in children and adults. The size of nuclei.C D’Agostino, Etienne De Clara, Adriano Chiò — 2006
• MELANOTIC MEDULLOBLASTOMA OF THE CEREBELLUMJae Hoon Sung, Angeline R. Mastri, Edward Segal — 1973
• Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.T Haas, M Kool — 2007
• The results of the treatment of childhood medulloblastoma with radiotherapy at Kaunas University of Medicine Hospital in 1994-2000.Giedrė Rutkauskienė, Liutauras Labanauskas, Laimonas Jaruševičius — 2006
• MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma CellsPooja Panwalkar, Aliasgar Moiyadi, Atul Goel — 2015